SPHAR Antikörper (C-Term)

Produktnummer ABIN185090

Produktdetails anti-SPHAR Antikörper

Target: SPHAR (S-Phase Response (Cyclin Related) (SPHAR))

Bindungsspezifität: C-Term

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Applikation: ELISA

Verwendungszweck: SPHAR

Sequenz: NVSFMIDLQA AHF

Homologie: Human

Aufreinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Güteklasse: Recent

Immunogen: C-NVSFMIDLQAAHF

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

DS WB Results: Not yet tested - our routinely used western blotting protocol does not allow detection of proteins as small as the predicted size of approx. 7.5 kDa according to NP_006533. Therefore we cannot recommend an optimal concentration and the product is investigative grade. Have any further splice variants/modified forms been reported?

Peptide ELISA: antibody detection limit dilution 1:2000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Details zu SPHAR

Target: SPHAR (S-Phase Response (Cyclin Related) (SPHAR))

Andere Bezeichnung: SPHAR (SPHAR Produkte)

Synonyme: RP4-803J11.4 antikoerper, S-phase response (cyclin related) antikoerper, SPHAR antikoerper

Hintergrund: SPHAR, S-phase response (cyclin-related), MGC88280, RP4-803J11.4, S-phase response (cyclin related)

Gen-ID: 10638

NCBI Accession: NP_006533